These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12562274)

  • 1. Practice guidelines on the reporting of smudge cells in the white blood cell differential count.
    Macdonald D; Richardson H; Raby A
    Arch Pathol Lab Med; 2003 Jan; 127(1):105. PubMed ID: 12562274
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility of Counting Smudge Cells as Lymphocytes in Differential Leukocyte Counts Performed on Blood Smears of Patients With Established or Suspected Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Gulati G; Ly V; Uppal G; Gong J
    Lab Med; 2017 May; 48(2):137-147. PubMed ID: 28371883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential diagnosis of absolute lymphocytosis].
    Gähler A; Cogliatti S; Korte W
    Ther Umsch; 2004 Feb; 61(2):157-60. PubMed ID: 15018399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of smudge cell percentage in chronic lymphocytic leukemia. Facts or artifacts? Methodological considerations and literature review.
    La Gioia A; Chiarugi P; Fumi M; Fiorini F; Giampietro C; Michelucci E; Veroni F; Fiorini M; Aquila F; Rocco V; Pellegrini G
    Clin Chem Lab Med; 2022 Oct; 60(11):e246-e249. PubMed ID: 36030427
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.
    Gogia A; Raina V; Gupta R; Gajendra S; Kumar L; Sharma A; Kumar R; Vishnubhatla S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):514-7. PubMed ID: 24656596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathological classification of chronic B-lymphoproliferative disorders].
    Bontoux C; Bruneau J; Molina TJ
    Presse Med; 2019; 48(7-8 Pt 1):792-806. PubMed ID: 31447335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated quantification of apoptosis in B-cell chronic lymphoproliferative disorders: a prognostic variable obtained with the Cell-Dyn Sapphire (Abbott) automated hematology analyzer.
    Fumi M; Martins D; Pancione Y; Sale S; Rocco V
    Int J Lab Hematol; 2014 Dec; 36(6):628-35. PubMed ID: 24888697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biclonality versus intraclonal evolution of a single tumor cell clone in B-cell chronic lymphoproliferative disorders.
    Dunphy CH
    Haematologica; 2006 Mar; 91(3):292A. PubMed ID: 16531249
    [No Abstract]   [Full Text] [Related]  

  • 11. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.
    Johansson P; Eisele L; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J; Nückel H
    Leuk Res; 2010 Jul; 34(7):892-8. PubMed ID: 20353875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basket cells or shadow cells of Gumprecht: a scanning electron microscope study, and the correlation between percentages of basket cells, and cells with altered chromatin structure (dense cells), in chronic lymphocytic leukemia.
    Binet JL; Baudet S; Mentz F; Chevance A; Lesty C; Blanc C; Michel A; Merle-Beral H
    Blood Cells; 1993; 19(3):573-81; discussion 582-9. PubMed ID: 8018940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytological characteristics of reactive lymphadenopathies and various criteria of differential diagnosis of non-Hodgkin lymphoma].
    Bychkova EN
    Lab Delo; 1980; (4):205-10. PubMed ID: 6155541
    [No Abstract]   [Full Text] [Related]  

  • 15. Automated differential white blood cell count and cytological analysis can detect near-tetraploid cells in chronic lymphoproliferative disorders.
    Settegrana C; Chapiro E; Frere C; Davi F; Choquet S; Leblond V; Cosson A; Nguyen-Khac F; Maloum K
    Int J Lab Hematol; 2019 Oct; 41(5):e104-e108. PubMed ID: 30831003
    [No Abstract]   [Full Text] [Related]  

  • 16. Present nosography of lymphoproliferative disorders.
    Raphael M; Binet JL
    Acta Haematol; 1987; 78 Suppl 1():142-5. PubMed ID: 2893505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Velasquez WS; Butler JJ; LeMaistre A; Lepe-Zuniga J; Keating MJ; Koller CA; Gutterman JU
    Am J Hematol; 1990 Mar; 33(3):189-97. PubMed ID: 2405649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphoproliferative syndrome in a 87-year-old patient: leukemic phase of mantle cell lymphoma or chronic lymphoid leukemia].
    André E; Klapczynski F; Siguret V; Bornand A; Gaussem P
    Ann Biol Clin (Paris); 1997; 55(3):235-7. PubMed ID: 9238426
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic significance of nucleolar markers in chronic lymphocytic leukemia].
    Loseva MI; Levitan NV; Degtiareva MM; Panacheva LA
    Gematol Transfuziol; 1990 Nov; 35(11):22-4. PubMed ID: 2283022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell sizing in chronic lymphoproliferative disorders: an aid to differential diagnosis.
    Alexander HD; Markey GM; Nolan RL; Morris TC
    J Clin Pathol; 1992 Oct; 45(10):875-9. PubMed ID: 1430257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.